+1-786-628-7980
Sign Up/Sign In 
The Measles Market is projected to reach USD 3.41 Billion by 2032 at 7.9% CAGR during the forecast period 2023-2032.
The measles market is driven primarily by efforts to control and eliminate this highly contagious viral disease through vaccination programs. Measles vaccines, including the MMR (measles, mumps, and rubella) vaccine, are the cornerstone of preventive strategies. The global market is characterized by the production and distribution of these vaccines, predominantly by major pharmaceutical companies such as Merck, GlaxoSmithKline, and Sanofi Pasteur.
Growing awareness about the importance of vaccination, coupled with government and non-governmental organization initiatives, has significantly boosted the measles vaccine market. The World Health Organization (WHO) and UNICEF play pivotal roles in coordinating immunization campaigns, particularly in low- and middle-income countries where measles outbreaks are more prevalent.
Get Free Sample PDF Brochure @
https://www.marketresearchfuture.com/sample_request/4449
Market Segmentation
The measles market is segmented by vaccine type, end-user, and region. Vaccine types include monovalent and combination vaccines (e.g., MMR – measles, mumps, rubella). End-users are categorized into hospitals, clinics, and vaccination centers. Regionally, the market is divided into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The segmentation allows for targeted strategies in vaccine distribution, public health initiatives, and healthcare infrastructure improvements. Key factors driving the market include increased vaccination awareness, government initiatives, and outbreaks in under-vaccinated regions.
Key Players
Abbott (US), Novartis AG (Switzerland), Biomedical diagnostics (US), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic (Denmark), MedImmune (US Astellas Pharma Inc. (Japan), CSL Limited (Australia), Emergent BioSolutions Inc. (US), and GlaxoSmithKline plc (US), and others.
Regional Analysis
The Americas account for a significant share of the market owing to the presence of huge patient population with various diseases. According to the Autoimmune Registry, in 2012, 14.7 million people in the US were suffering from autoimmune diseases. Auto immune diseases is one of the major factors responsible for measles. Additionally, high healthcare spending and increasing government support for research & development have fueled the market growth in this region.
Browse In-depth Market Research Report (80 Pages) on Measles:
https://www.marketresearchfuture.com/reports/measles-market-4449
Europe holds the second largest market, which is followed by Asia Pacific. Asia Pacific is the fastest growing market for measles. Presence of huge population base, rapidly developing economy, and presence of huge opportunity for the development of the market have boosted the market growth. India and China are the major contributor to the growth of the market owing to developing healthcare sector and increasing health care expenditure.
Discover More Research Reports on Healthcare Industry by Market Research Future:
The Middle East & Africa holds the lowest share in the market due to limited availability of medical facilities. UAE, Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas the African region is expected to witness a moderate growth.
Medical Second Opinion Market Research Report: Information By Application (Cancer, Diabetes, Cardiac Disorders, Neurological Disorders, Respiratory Disorders and Ocular Disorders), By Source of Service (In-House and Outsourced), By Services (Medical Condition Management, Post-Acute Care Nursing and Medical Peer Review Services), By Type (Hospitals Physicians/Specialties, Online Physicians Portal, Medical Second Opinion Companies and Health Insurance Companies), And By Region
Orthopedic Implants Market Research Report Information By Product Biomaterial (Spinal Implants, Reconstructive Joint Implants, Orthobiologics and others), By Biomaterial (Metallic, Ceramic, And Others), By End Users (Hospitals & Ambulatory Surgery, Orthopedic Clinics, And Others), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032
EHR-EMR Market Research Report Information By Component (Software, Hardware), By Application (Specialty-Based and General Application), By Mode Of Delivery (Cloud-Based), By End User (Hospitals and Clinics and Ambulatory Care Centers) – Forecast till 2032
Obesity Treatment Market Research Report Information By Surgery Type (Biliopancreatic diversion with Duodenal Switch (BPD/DS), Adjusting Gastric Banding, Roux-en-Y Gastric Bypass, Sleeve gastrectomy, and Endoscopic Procedures), By Diagnosis (Appetite suppressants, Combination drugs, Malabsorption, and Satiety drugs), By End-User (Hospitals, and Clinics), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) – Market Forecast Till 2032
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
